Virological efficacy of PI monotherapy for HIV-1 in clinical practice

BACKGROUND: Clinical trials of PI monotherapy indicate that most participants maintain viral suppression and emergent protease resistance is rare. However, outcomes among patients receiving PI monotherapy for clinical reasons, such as toxicity or adherence issues, are less well studied. METHODS: An...

Descripción completa

Detalles Bibliográficos
Autores principales: El Bouzidi, Kate, Collier, Dami, Nastouli, Eleni, Copas, Andrew J., Miller, Robert F., Gupta, Ravindra K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079296/
https://www.ncbi.nlm.nih.gov/pubmed/27402006
http://dx.doi.org/10.1093/jac/dkw265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079296/
https://www.ncbi.nlm.nih.gov/pubmed/27402006
http://dx.doi.org/10.1093/jac/dkw265

Ejemplares similares